Lotus Pharmaceutical Co., Ltd. (1795)
Market Closed
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
180. 00
0
0%
NT$
80.36B Market Cap
20.79 P/E Ratio
- Div Yield
1.4M Volume
26.65 Eps
NT$ 180
Previous Close Want to track 1795 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lotus Pharmaceutical Co., Ltd. (1795) Statistics
Valuation metrics
Market Cap 80.36B
Enterprise value 99.56B
Trailing P/E (ttm) 12.49
Forward P/E -
PEG ratio -0.57
Price/Sales (ttm) 1.67
Price/Book (mrq) 1.93
Enterprise Value/Revenue 3.5
Enterprise Value/EBITDA 10.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 712.37K
Average volume (90 days) 1.16M
Price summary
52-Week low 168.31
52-Week high 364.76
Beta -
50-Day moving average 181.83
200-Day moving average 197.07
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.57
Trailing annual dividend yield 0.0142%
5-Year annual dividend yield -
Payout ratio 0.4
Dividend Date 5 Oct 2026
Ex-Dividend Date 31 Aug 2026
Last split factor 1,013:1,000
Last split Date 31 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.16%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 109.56
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 14.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 24.33
Total debt (mrq) -
Total Debt/Equity (mrq) 2.4
Current ratio (mrq) 1.46%
Book value per share (mrq) 93.48
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
